Table 2 ∣.
NP formulations | Weight (μg) | |||
---|---|---|---|---|
siRNA/G0-C14 (ratio) |
PLGA | DSPE-PEG | DSPE-PEG-S2P (from Step 24) |
|
S2P0 NPs | 25/250 | 2500 | 1000 | 0 |
S2P10 NPs | 25/250 | 2500 | 900 | 100 |
S2P30 NPs | 25/250 | 2500 | 700 | 300 |
S2P50 NPs | 25/250 | 2500 | 500 | 500 |
NP formulations | Weight (μg) | |||
---|---|---|---|---|
siRNA/G0-C14 (ratio) |
PLGA | DSPE-PEG | DSPE-PEG-S2P (from Step 24) |
|
S2P0 NPs | 25/250 | 2500 | 1000 | 0 |
S2P10 NPs | 25/250 | 2500 | 900 | 100 |
S2P30 NPs | 25/250 | 2500 | 700 | 300 |
S2P50 NPs | 25/250 | 2500 | 500 | 500 |